Blood Culture Test Market

Blood Culture Test Market - New report by MarketsandMarkets™

The overall market of blood culture test is projected to reach $4,768.9 million by 2021 from $3, 252.6 million in 2016, at a CAGR of 8.0% during the forecast period. The base year considered for the study is 2015 and the forecast for the market size is provided for the period between 2016 and 2021.

To know about the assumptions considered for the study download the pdf brochure

Companies are focusing on organic as well as inorganic growth strategies such as new product launches and product approvals; agreements, partnerships, and collaborations; expansions; and acquisitions. New product launches and product approvals accounted for the largest share of the overall growth strategies adopted by market players between 2013 and 2016. Various new and technologically advanced products were launched during this period. For instance, in April 2016, Brucker Corporation introduced an upgraded version of its MALDI Biotyper (MBT) system. The improvised version is for Research Use Only (RUO), which includes disposable Biotargets 96, MBT Subtyping, and Gram-negative carbapenemase resistance testing. In addition to the new product launches, prominent players in this market received product approvals to market their products in the blood culture tests market. Some of the recent approvals include the U.S. FDA approval for BACTEC PEDS Plus/F plastic blood culture bottles (March 2016), U.S. FDA approval for T2 Candida Panel (September 2014), and CE-mark approval for BacT/ALERT VIRTUO (July 2014). Such product launches and approvals help companies to enhance their product offerings and leverage growth opportunities in the market.

Key players that adopted this growth strategy include bioMérieux SA (France), Becton, Dickinson and Company (U.S.), Cepheid, Inc. (U.S.), Nanosphere, Inc. (U.S.), Bruker Corporation (U.S.), IRIDICA (U.S.), and Roche Diagnostics (Switzerland).

Related Reports:

Blood Culture Test Market Size & Share by Application (Bacteremia, Fungemia), Product (Consumables, Instrument), Method (Automated, Manual), Technology (PCR, Microarray, Proteomic) & End User (Hospital Laboratories, Reference Laboratories) - Global Forecast to 2021

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Report Code
MD 3252
Published ON
Jul, 2016
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Blood Culture Test Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved